VGM Research Note — Income Meets Leverage
VGM’s high tax-exempt distribution meets 36.52% effective leverage and a market price that now stands above the fund’s underlying net asset value.
Research Notes
WULF Research Note — Foundry Strength Under Pressure
WULF’s contracted AI-infrastructure opportunity faces construction, financing, customer concentration and weak legacy mining economics today.
RCL Research Note — Franchise Strength Meets an Earnings Test
Royal Caribbean’s franchise quality remains clear, while net yield, fuel costs and the July report will test whether its premium valuation endures.
FITBPA Research Note — Issuer Strength Meets Perpetual-Rate Risk
Fifth Third’s preferred credit remains sound, while perpetual duration and thin liquidity keep FITBPA sensitive to Treasury yields and capital evidence.
XOVR Research Note — Private-Market Access Meets a Catalyst
XOVR’s scarce SpaceX access comes with private-mark uncertainty and correlated growth exposure ahead of a concentrated August catalyst window.
Market Structure: Financials Lead as Technology Resets — July 20, 2026
Financials dominate the candidate board, healthcare leads quietly, and technology’s longer trend faces a sharp near-term reset.
CRWD Research Note — Strength Still Needs Confirmation
CrowdStrike’s recurring-revenue engine is reaccelerating, but valuation and a weak technology tape leave the setup dependent on confirmation.
COST Research Note — Quality Needs Confirmation
Costco’s membership engine remains strong, but slowing comparable sales and heavy technical resistance leave the valuation dependent on confirmation.
BIVI Research Note — Binary Catalysts Demand Patience
BioVie faces two near-term clinical catalysts, but prior trial failure, liquidity, and financing risk favor patience.
AVGO Research Note — AI Demand Meets a Timing Test
Broadcom’s AI demand thesis remains constructive, but sector rotation and hyperscaler spending create a timing test.